MAPK3 and malignant colon neoplasm: Pharmacological modulation of CaM by KN93, a specific inhibitor, in HCT116 cells (an in vitro model of human colon cancer) was found to drastically decrease colon cancer cell invasion and migration via ERK1/2 or p38 signalling [138].